Literature DB >> 26132952

Vaccine against Pneumococcal Pneumonia in Adults.

Marc J M Bonten, Susanne M Huijts, Marieke Bolkenbaas.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26132952     DOI： 10.1056/NEJMc1505366

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.

Authors:  Francisco Arancibia; Mauricio Ruiz
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

2.  Adaptation of antibiotic treatment to clinical practice guidelines in patients aged ⩾65 years hospitalised due to community-acquired pneumonia.

Authors:  M A Fernandez-Sierra; M T Rueda-Domingo; M M Rodriguez-Del-Aguila; M J Perez-Lozano; L Force; T Fernandez-Villa; J Astray; M Egurrola; J Castilla; F Sanz; D Toledo; A Dominguez
Journal:  Epidemiol Infect       Date:  2018-08-02       Impact factor: 4.434

3.  Personalizing pneumococcal vaccination recommendations: The Saudi Thoracic Society guidelines.

Authors:  Antoni Torres
Journal:  Ann Thorac Med       Date:  2016 Apr-Jun       Impact factor: 2.219

Review 4.  Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness.

Authors:  C Trucchi; C Paganino; F Ansaldi
Journal:  J Prev Med Hyg       Date:  2015-08-31

Review 5.  Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).

Authors:  C T Rieger; B Liss; S Mellinghoff; D Buchheidt; O A Cornely; G Egerer; W J Heinz; M Hentrich; G Maschmeyer; K Mayer; M Sandherr; G Silling; A Ullmann; M J G T Vehreschild; M von Lilienfeld-Toal; H H Wolf; N Lehners
Journal:  Ann Oncol       Date:  2018-06-01       Impact factor: 32.976

6.  Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs.

Authors:  Claire Dupuis; Ayman Sabra; Juliette Patrier; Gwendoline Chaize; Amine Saighi; Céline Féger; Alexandre Vainchtock; Jacques Gaillat; Jean-François Timsit
Journal:  Crit Care       Date:  2021-01-10       Impact factor: 9.097

7.  Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.

Authors:  Raul Isturiz; Lindsay Grant; Sharon Gray; Ronika Alexander-Parrish; Qin Jiang; Luis Jodar; Paula Peyrani; Kimbal D Ford; Michael W Pride; Wesley H Self; Francis Counselman; Gregory Volturo; Luis Ostrosky-Zeichner; Richard G Wunderink; Robert Sherwin; J Scott Overcash; Thomas File; Julio Ramirez
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999

8.  Association between PCV13 pneumococcal vaccination and risk of hospital admissions due to pneumonia or sepsis among patients with haematological malignancies: a single-centre retrospective cohort study in Israel.

Authors:  Regina Draliuk; Efrat Shadmi; Meir Preis; Efrat Dagan
Journal:  BMJ Open       Date:  2022-04-15       Impact factor: 3.006

9.  Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.

Authors:  Brandon Essink; Charu Sabharwal; Kevin Cannon; Robert Frenck; Himal Lal; Xia Xu; Vani Sundaraiyer; Yahong Peng; Lisa Moyer; Michael W Pride; Ingrid L Scully; Kathrin U Jansen; William C Gruber; Daniel A Scott; Wendy Watson
Journal:  Clin Infect Dis       Date:  2022-08-31       Impact factor: 20.999
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.